Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials

Published:2022 Issue:8 Volume:69 Page:959-969
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Long Tao¹,Lin Jin-ting²,Lin Min-hua²,Wu Qian-long²,Lai Jian-mei²,Li Sheng-zhen²,Zhou Zi-chao²,Zeng Ji-yuan²,Huang Jia-shuan²,Zeng Chun-ping¹,Lai Yao-ming³

Affiliation:

1. Department of Endocrinology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510700, China

2. Department of Pediatrics, Pediatrics School, Guangzhou Medical University, Guangzhou, 511436, China

3. Department of Rehabilitation Medicine, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510700, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/8/69_EJ21-0692/_pdf

Reference32 articles.

1. 1 Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, et al. (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375: 2215–2222.

2. 2 (2015) IDF Diabetes Atlas, 7th edn. International Diabetes Federation. Brussels, Belgium. http://www.diabetesatlas.org/ accessed on November 1, 2021.

3. 3 (2019) IDF Diabetes Atlas, 9th edn. International Diabetes Federation. Brussels, Belgium. http://www.diabetesatlas.org/ accessed on November 1, 2021.

4. 4 International Diabetes Federation Guideline Development Group (2014) Global guideline for type 2 diabetes. Diabetes Res Clin Pract 104: 1–52.

5. 5 Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38: 140–149.